Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
QURE
#2169
uniQure N.V.
15.6
3
-9.76%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-9.76%
Aylık değişim
-34.90%
6 aylık değişim
-1.01%
Yıllık değişim
+33.02%
Önceki kapanış
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
Hacim
137
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
QURE
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
48.74 M
54.08 M
54.75 M
54.87 M
62.29 M
—
Valuation ratios
Enterprise value
-11.32 M
796.07 M
363.11 M
511.07 M
3.04 B
4.71 B
Price to earnings ratio
-1
-3.59
-2.43
-3.59
-13.36
-22.97
Price to sales ratio
8.34
31.68
25.69
49.83
197.14
304.34
Price to cash flow ratio
1.33
4.7
3.17
4.11
19.96
31.94
Price to book ratio
0.47
127.24
2.71
7
12.28
149.22
Enterprise value to EBITDA ratio
0.3
54.59
-9.05
-10.18
-66.77
-31.41
Profitability ratios
Return on assets %
0.07
0.13
0.07
-0.06
-0.09
0.05
Return on equity %
0.8
10.85
1.3
-9.42
-0.35
2.37
Return on invested capital %
-79.67
-94.17
-90.54
-98.03
-90.99
-373.73
Gross margin %
88.46
88.14
87.43
87.53
89.25
352.35
Operating margin %
-1 758.99
-877.76
-2 509.96
-833.62
-1 378.95
-5 600.29
EBITDA margin %
-225.71
-821.74
-191.38
15.91
-12.02
-1 009.24
Net margin %
1 940.45
1 403.2
2 784.75
-716.82
-2 175.87
1 295.26
Liquidity ratios
Quick ratio
6.51
—
—
—
—
—
Current ratio
6.51
9.74
11.99
9.98
7.12
38.84
Inventory turnover
-0.1
—
—
—
—
—
Asset turnover
0
0.01
0
0.01
0.01
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0.09
0.09
0.09
0.06
0.32
Long term debt to total equity ratio
0.92
-7.6
1.53
-12.95
0.23
-18.79
Per share metrics
Operating cash flow per share
-0.75
-1.09
-0.83
-0.73
-0.29
-2.94
EBIT per share
-0.14
-0.93
-0.1
-0.02
-0.04
-1.09
EBITDA per share
-0.11
-0.88
-0.06
0.02
-0.01
-0.93
Total debt per share
—
—
—
—
—
—
Cash per share
8.97
7.56
7.7
6.91
12.42
34.6
Net current asset value per share
9.55
8.02
8.2
7.49
12.82
36.53
Tangible book value per share
-0.92
-0.92
-1.16
-1.92
2.31
-1.69
Working capital per share
8.09
7.2
7.51
6.74
11.02
32.47
Book value per share
1.15
-0.14
0.63
-0.07
4.09
4.52
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
Haberler
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
AMT-130’un düzenleyici süreci yaklaşırken uniQure kazançları odakta
uniQure earnings in focus as AMT-130 regulatory path looms
FDA yorumları sonrası Stifel’den uniQure değerlendirmesi
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
UniQure hisseleri FDA’nın gen tedavisi yorumlarıyla düştü
UniQure stock tumbles on FDA comments about gene therapy trial
uniQure hissesi Wolfe Research tarafından Peerperform ile başlatıldı
uniQure stock initiated at Peerperform by Wolfe Research